During the past decade, Harlem Prevention Center CRS conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harlem Prevention Center CRS" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "HIV Prevention Trials Network" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "ViiV Healthcare" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Harlem Prevention Center CRS" are "HIV Infections" (4 trials), "COVID-19" (1 trials), "HIV Prevention" (1 trials), "Healthy" (1 trials) and "SARS-CoV-2" (1 trials). Many other conditions were trialed in "Harlem Prevention Center CRS" in a lesser frequency.

Most popular intervention types in "Harlem Prevention Center CRS" are "Biological" (4 trials), "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "10-1074" (1 trials), "Ad26.Mos4.HIV" (1 trials), "CAB LA" (1 trials), "Cabotegravir Oral Tablet" (1 trials) and "Clade C and Mosaic gp140 HIV bivalent vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Harlem Prevention Center CRS" are 6 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Harlem Prevention Center CRS". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Harlem Prevention Center CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Harlem Prevention Center CRS, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".